Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes
Priyanka Maridhi Nanjireddy, Scott H. Olejniczak, Nataliya P. Buxbaum
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17

Showing 17 citing articles:

CAR-T cell manufacturing landscape—Lessons from the past decade and considerations for early clinical development
Juliana Dias, John García, Giulia Agliardi, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 2, pp. 101250-101250
Open Access | Times Cited: 18
Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review
Xinyan Wu, Zhigang Zhou, Qiang Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33
Eras of designer Tregs: Harnessing synthetic biology for immune suppression
Karoliina Tuomela, Kevin Salim, Megan K. Levings
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 250-267
Open Access | Times Cited: 12
Label free metabolic imaging to enhance the efficacy of Chimeric Antigen Receptor T cell therapy
Dan L. Pham, Daniel Cappabianca, Matthew H. Forsberg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
La dolce vita: fueling chimeric antigen receptor (CAR) T cells with Glut1 to improve therapeutic efficacy
Karen Slattery, David K. Finlay, Phillip K. Darcy
Immunometabolism (2025) Vol. 7, Iss. 1, pp. e00055-e00055
Open Access
Phosphoglycerate mutase regulates Treg differentiation through control of serine synthesis and one-carbon metabolism
Wesley H. Godfrey, Kaho Cho, Xiaojing Deng, et al.
(2025)
Open Access
Phosphoglycerate mutase regulates Treg differentiation through control of serine synthesis and one-carbon metabolism
Wesley H. Godfrey, Kaho Cho, Xiaojing Deng, et al.
(2025)
Open Access
Role of metabolic transformation in cancer immunotherapy resistance: molecular mechanisms and therapeutic implications
Sandesh Shende, Jaishriram Rathored, Tanushree Budhbaware
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy
Nahum Puebla‐Osorio, Natalie W. Fowlkes, Hampartsoum B. Barsoumian, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy
Wanxin Zhao, Yizhou Yao, Qihong Li, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116439-116439
Closed Access | Times Cited: 2
Challenges and interventions of chimeric antigen receptor-T cell therapy in solid tumors.
Shasha Liu, Yi Zhang
PubMed (2023) Vol. 35, Iss. 3, pp. 239-244
Closed Access | Times Cited: 4
Metabolic Landscape of Osteosarcoma: Reprogramming of Lactic Acid Metabolism and Metabolic Communication
Linbang Wang, Xinyu Dou, Linzhen Xie, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 1
Endogenous CD28 drives CAR T cell responses in multiple myeloma
M Lieberman, Jason H. Tong, Nkechi U. Odukwe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Label free metabolic imaging to enhance the efficacy of chimeric antigen receptor T cell therapy
Melissa C. Skala, Dan L. Pham, Daniel Cappabianca, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Applying metabolic control strategies to engineered T cell cancer therapies
Andrea Fox, John Blazeck
Metabolic Engineering (2024) Vol. 86, pp. 250-261
Closed Access
GPX4 and FSP1, key ferroptosis regulators, are critical for T cell functions and CAR-T antitumor activity
Małgorzata Bajor, Marta Kłopotowska, Iwona Baranowska, et al.
Research Square (Research Square) (2024)
Open Access
Comprehensive genome editing confers ‘off-the-shelf’ CAR-T cells superior efficacy against solid tumors
Ryan Murray, Nuria Roxana Romero Navarrete, Kashvi Desai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top